Pregnane X Receptor Mediates Dyslipidemia Induced by the HIV Protease Inhibitor Amprenavir in Mice

被引：0
|
作者：
Helsley, Robert Nathaniel [1 ]
Sui, Yipeng [1 ]
Ai, Ni [2 ]
Park, Se-Hyung [1 ]
Welsh, William J. [2 ]
Zhou, Changcheng [1 ]
机构：
[1] Univ Kentucky, Grad Ctr Nutr Sci, Lexington, KY USA
[2] Univ Med & Dent New Jersey, Dept Pharmacol, Piscataway, NJ 08854 USA
来源：
FASEB JOURNAL | 2013年 / 27卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
1169.20
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Pregnane X Receptor Mediates Dyslipidemia Induced by the HIV Protease Inhibitor Amprenavir in Mices
    Helsley, Robert N.
    Sui, Yipeng
    Ai, Ni
    Park, Se-Hyung
    Welsh, William J.
    Zhou, Changcheng
    MOLECULAR PHARMACOLOGY, 2013, 83 (06) : 1190 - 1199
  • [2] Amprenavir: A new HIV protease inhibitor
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 1999, 41 (1057): : 64 - 66
  • [3] Pregnane X Receptor Mediates Atherosclerosis Induced by Dicyclohexyl Phthalate in LDL Receptor-Deficient Mice
    Liu, Jingwei
    Hernandez, Rebecca
    Li, Xiuchun
    Meng, Zhaojie
    Chen, Hong
    Zhou, Changcheng
    CELLS, 2022, 11 (07)
  • [4] A human immunodeficiency virus protease inhibitor is a novel functional inhibitor of human pregnane x receptor
    Healan-Greenberg, Christine
    Waring, Jeffrey F.
    Kempf, Dale J.
    Blomme, Eric A. G.
    Tirona, Rommel G.
    Kim, Richard B.
    DRUG METABOLISM AND DISPOSITION, 2008, 36 (03) : 500 - 507
  • [5] Resistance to the HIV protease inhibitor amprenavir in vitro and in clinical studies -: A review
    Tisdale, M
    Myers, R
    Randall, S
    Maguire, M
    Ait-Khaled, M
    Elston, R
    Snowden, W
    CLINICAL DRUG INVESTIGATION, 2000, 20 (04) : 267 - 285
  • [6] Resistance to the HIV Protease Inhibitor Amprenavir In Vitro and in Clinical StudiesA Review
    Margaret Tisdale
    Richard Myers
    Sharon Randall
    Michael Maguire
    Mounir Ait-Khaled
    Rob Elston
    Wendy Snowden
    Clinical Drug Investigation, 2000, 20 : 267 - 285
  • [7] Amprenavir - A protease inhibitor for the treatment of patients with HIV-1 infection
    Reddy, P
    Ross, J
    FORMULARY, 1999, 34 (07) : 567 - +
  • [8] The role of C/EBP homologous protein in HIV protease inhibitor-induced dyslipidemia
    Wang, Yun
    Zhang, Luyong
    Studer, Elaine
    Hylemon, Phillip B.
    Pandak, William M.
    Zhou, Huiping
    FASEB JOURNAL, 2011, 25
  • [9] Pregnane X receptor promotes ethanol-induced hepatosteatosis in mice
    Choi, Sora
    Neequaye, Prince
    French, Samuel W.
    Gonzalez, Frank J.
    Gyamfi, Maxwell A.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2018, 293 (01) : 1 - 17
  • [10] Effect of the HIV protease inhibitor amprenavir on the growth and differentiation of primary gingival epithelium
    Israr, Mohd
    Mitchell, Danielle
    Alam, Samina
    Dinello, Donald
    Kishel, Joseph J.
    Meyers, Craig
    ANTIVIRAL THERAPY, 2010, 15 (02) : 253 - 265
12345